Clinical trial Recruiting at 1 site Interventional Ages 50 to 75

Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

Official title: Uppsala Self-Screening of Cardiovascular Health: A Randomized Controlled Trial of Home-Based Multimodal Cardiovascular Screening Versus Usual Care in Middle-Aged and Older Adults

Run by Uppsala University · NCT07614659 · Data updated 2026-11-12

This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

More Hypertension trials

Quick facts

Study typeInterventional
Ages50 Years to 75 Years
SexAll
Enrollment45000 (estimated)
SponsorUppsala University
Academic / other
Locations1 site (Uppsala)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedDecember 2027
Study endsDecember 2037
Registry record updatedJune 30, 2026
Trial IDNCT07614659 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Residents of Region Uppsala aged 50, 55, 60, 65, 70, or 75 who can provide informed consent.

Probably not a fit

Individuals unable to use home testing devices or who do not have actionable cardiovascular risks may see no personal benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

U-SCREEN is a pragmatic randomized trial in Region Uppsala that assigns residents aged 50, 55, 60, 65, 70 or 75 to either a home-based, multimodal screening package or to usual care. The screening arm includes a home blood pressure monitor, a dried blood spot kit for ApoB, HbA1c and creatinine, and a digital questionnaire to assess risk. Primary goals are to see if this approach identifies more actionable risk factors, influences preventive treatment, and impacts cardiovascular events, healthcare use, costs, and patient-reported outcomes. The study uses register-based follow-up with a 1:1 randomization and targets up to 10,000 participants recruited between 2024 and 2027. It is led by Johan Sundström with Region Uppsala Public Health and Care and Uppsala University Hospital involved in the conduct.

Why it matters

Potential benefit: If successful, participants could receive earlier detection of treatable cardiovascular risks and faster initiation of preventive care.

How similar studies have gone: Digital and home-based screening approaches have shown potential in identifying risk factors, but large-scale population-level effectiveness remains to be proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Resident in Region Uppsala, Sweden
* Turning 50, 55, 60, 65, 70 or 75 years during recruitment period
* Able to provide informed consent

Exclusion Criteria:

* Inability to provide informed consent
* Protected identity

Where it's running

  • Uppsala University Hospital
    Uppsala, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.